Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.
• Fenoldopam (a medicine that rapidly widens and relaxes blood vessels) probably reduces the risk of developing acute kidney injury (AKI) (a condition where the kidneys suddenly lose their ability to ...
"Arch Biopartners doses first subject in trial of acute kidney injury treatment" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...
Acute kidney injury (AKI) is a rapid deterioration in kidney function that occurs within 48 hours of an initiating event and is associated with an absolute increase in serum creatinine of ≥26.4 ...
We describe a case of preeclampsia with severe features, including HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) and acute kidney injury (AKI) that developed following caesarian ..
Credit: Natali _ Mis / Shutterstock. Canadian clinical trial company Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of LSALT peptide (Metablok) for preventing ...
short-term (called acute kidney injury or AKI), which is reversible with timely treatment; and long-term (called chronic kidney disease or CKD), which is usually irreversible. Holiday deals ...